Many patients find this investment in their health is worth more than years of failed attempts elsewhere
There's a lot to unpack, so we've structured our thoughts into three distinct sectionsfeel free to peruse the whole post or jump forward to specific areas of interest using the links below: We'll start by sharing our about where the innovation race is headingand what it means for the industry key insights and predictions From there, we'll overview (including key differentiators between major competitors Eli Lilly and Novo Nordisk) what the race has looked to date Finally, we'll go deep on the that will define the innovation race moving forward: five vectors of innovation GLP-1 innovation: Key insights and predictions GLP-1s are more than a blockbuster drug class, they signal a profound reordering of how chronic disease is managed, financed, and even understood
Important safety information: Mounjaro (tirzepatide) and Wegovy (semaglutide) are prescription-only medications
Gallbladder disease, gastroparesis, retinopathy, and other complications may require examination or imaging rather than blood testing alone
Animal studies indicate a plasma half-life of approximately 1-2 hours, with rapid tissue distribution facilitating its role in wound contraction and epithelialization